Anthem (NASDAQ:ANTX) Director Sells $37,027.00 in Stock

Anthem, Inc. (NASDAQ:ANTX) Director Robin Shane Readnour sold 6,100 shares of Anthem stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $6.07, for a total transaction of $37,027.00. Following the completion of the sale, the director owned 562,715 shares of the company’s stock, valued at $3,415,680.05. This trade represents a 1.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Robin Shane Readnour also recently made the following trade(s):

• On Tuesday, September 8th, Robin Shane Readnour sold 10,019 shares of Anthem stock. The stock was sold at an average price of $6.02, for a total transaction of $60,314.38.
• On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The stock was sold at an average price of $6.01, for a total value of $212,766.02.

Anthem Stock Down 0.7%

Shares of Anthem stock opened at $5.69 on Friday. The stock has a 50 day moving average price of $5.38 and a two-hundred day moving average price of $4.47. The stock has a market capitalization of $214.74 million, a P/E ratio of -5.32 and a beta of -0.99. Anthem, Inc. has a 12-month low of $1.00 and a 12-month high of $7.19.

Anthem (NASDAQ:ANTX) last announced its earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Hedge Funds Weigh In On Anthem

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vivo Capital LLC bought a new position in shares of Anthem during the first quarter valued at $10,785,000. Seven Fleet Capital Management LP bought a new stake in shares of Anthem during the first quarter valued at approximately $683,000. Commodore Capital LP bought a new position in Anthem in the 1st quarter valued at $7,981,000. Spruce Street Capital LP bought a new position in Anthem in the first quarter valued at about $5,576,000. Finally, Ally Bridge Group NY LLC bought a new position in shares of Anthem in the 1st quarter valued at about $1,800,000. Institutional investors own 90.47% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ANTX. Wall Street Zen raised Anthem from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anthem in a research report on Monday, July 6th. Guggenheim started coverage on shares of Anthem in a research note on Monday, July 20th. They set a “buy” rating and a $9.00 target price for the company. Finally, Leerink Partners upgraded shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a research note on Thursday, May 14th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $9.00.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.